Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Bepectate vs Ferric Carboxymaltose in Iron Deficiency Anemia
NCT07687784Phase 3Not yet recruiting
- Sponsor
- AFT Pharmaceuticals
- Start
- Dec 2026
- Primary completion
- Jun 2028
- Countries
- 4
01
Overview
A Phase 3 trial of ferric bepectate in iron deficiency anemia (IDA), sponsored by AFT Pharmaceuticals. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
ferric bepectate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07687784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07687784.